These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28669388)

  • 1. Multivariate analysis of the immune response to a vaccine as an alternative to the repetition of animal challenge studies for vaccines with demonstrated efficacy.
    Chapat L; Hilaire F; Bouvet J; Pialot D; Philippe-Reversat C; Guiot AL; Remolue L; Lechenet J; Andreoni C; Poulet H; Day MJ; De Luca K; Cariou C; Cupillard L
    Vet Immunol Immunopathol; 2017 Jul; 189():58-65. PubMed ID: 28669388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility between a rabies vaccine and two canine combined vaccines against canine distemper, adenovirosis, parvovirosis, parainfluenza virus disease and leptospirosis, with or without canine coronavirus.
    Thibault JC; Bouvet J; Cupillard L; Cariou C; Oberli F
    Comp Immunol Microbiol Infect Dis; 2022 Jul; 86():101803. PubMed ID: 35429805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
    Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility between a rabies vaccine and a combined vaccine against canine distemper, adenovirosis, parvovirosis, parainfluenza virus and leptospirosis.
    Bouvet J; Cariou C; Poulard A; Oberli F; Cupillard L; Guigal PM
    Vet Immunol Immunopathol; 2018 Nov; 205():93-96. PubMed ID: 30459006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of the immune response to different rabies vaccines.
    Bommier E; Chapat L; Guiot AL; Hilaire F; Cariou C; Poulet H; Pialot D; De Luca K
    Vet Immunol Immunopathol; 2020 Feb; 220():109986. PubMed ID: 31855742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
    Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
    J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and serological response of wild dogs (Lycaon pictus) to vaccination against canine distemper, canine parvovirus infection and rabies.
    van Heerden J; Bingham J; van Vuuren M; Burroughs RE; Stylianides E
    J S Afr Vet Assoc; 2002 Mar; 73(1):8-12. PubMed ID: 12088076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
    Luo J; Shi H; Tan Y; Niu X; Long T; Zhao J; Tian Q; Wang Y; Chen H; Guo X
    Vaccine; 2016 Aug; 34(37):4392-8. PubMed ID: 27449079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin.
    Taguchi M; Namikawa K; Maruo T; Lynch J; Sahara H
    Vet Rec; 2010 Dec; 167(24):931-4. PubMed ID: 21262693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of different strategies of multivalent DNA-based vaccination against rabies and canine distemper in mice and dogs.
    Touihri L; Ahmed SB; Chtourou Y; Daoud R; Bahloul C
    Virol J; 2012 Dec; 9():319. PubMed ID: 23270301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
    Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
    Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
    Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
    Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Glucan as Trained Immunity-Based Adjuvants for Rabies Vaccines in Dogs.
    Paris S; Chapat L; Martin-Cagnon N; Durand PY; Piney L; Cariou C; Bergamo P; Bonnet JM; Poulet H; Freyburger L; De Luca K
    Front Immunol; 2020; 11():564497. PubMed ID: 33162977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Testing for immunogenic and protective properties of vaccine against tissue-inactivated rabies].
    Vrzal V; Cupera Z; Chumela J; Zatloukal L
    Vet Med (Praha); 1990 Feb; 35(2):87-95. PubMed ID: 2353410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
    Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine adenovirus based rabies vaccines.
    Tordo N; Foumier A; Jallet C; Szelechowski M; Klonjkowski B; Eloit M
    Dev Biol (Basel); 2008; 131():467-76. PubMed ID: 18634509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
    Larson LJ; Schultz RD
    Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermotolerance of an inactivated rabies vaccine for dogs.
    Lankester FJ; Wouters PAWM; Czupryna A; Palmer GH; Mzimbiri I; Cleaveland S; Francis MJ; Sutton DJ; Sonnemans DGP
    Vaccine; 2016 Nov; 34(46):5504-5511. PubMed ID: 27729174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.